SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 490.20
arrow_upward
+0.45%(+2.20) 1D
Oct 30, 5:00:00 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 488.00
High
SEKÂ 491.00
Low
SEKÂ 485.40
Mkt. cap
175.31B
Avg. vol.
335.45K
Volume
157.56K
P/E ratio
26.04
52-wk high
SEKÂ 492.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 18.83
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 488.00
High
SEKÂ 491.00
Low
SEKÂ 485.40
Mkt. cap
175.31B
Avg. vol.
335.45K
Volume
157.56K
P/E ratio
26.04
52-wk high
SEKÂ 492.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 18.83
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
Nasdaq's 5.3% October Slide Sets Up a Familiar Bet: History Points to a 24% Rebound
Yahoo Finance
·
1 hour ago
Trade Futures or S&P 500 Index Options? The IRS Treats 60% of Your Gains as Long-Term, Even on a Day Trade
The Motley Fool
·
49 minutes ago
This Dividend Stock Yielding Quadruple the S&P 500 Looks Like a Buy Right Now
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)